- Effective in treating chronic lymphocytic leukemia (CLL).
- Used for managing mantle cell lymphoma (MCL).
- Helps in controlling disease progression in patients with specific hematological cancers.
- Targeted therapy that minimizes damage to healthy cells.
- Improves overall survival rates in certain cancer patients.
- Can be used in patients who have received prior therapies.
- May reduce the need for more aggressive treatments like chemotherapy.
Ibitra 200 Capsule - Strip of 10
Prescription Required
Compositions : Itraconazole 200mg
₹193.68
(Incl. GST)
MRP :
(Incl. GST)
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Linux Laboratories
Recommended Substitute
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Ibitra 200 Capsule is a pharmaceutical product that contains the active ingredient Ibrutinib, which is classified as a Bruton's tyrosine kinase (BTK) inhibitor. This medication is primarily used in the treatment of various hematological malignancies, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Ibrutinib works by interfering with the signals that promote the growth and survival of cancer cells, thereby helping to control the disease. The formulation of Ibitra 200 Capsule ensures optimal bioavailability and efficacy, making it a vital component in the therapeutic regimen for patients diagnosed with these conditions. The capsule form allows for easy administration and absorption, contributing to patient compliance and overall treatment success. As a targeted therapy, Ibitra 200 Capsule represents a significant advancement in oncology, providing patients with a more effective option compared to traditional chemotherapy. It is essential for patients to consult their healthcare provider to determine if Ibitra 200 Capsule is appropriate for their specific medical condition and to discuss any potential risks or benefits associated with its use.
Product Details
Uses & Benefits
How Ibitra 200 Capsule works
- Ibrutinib selectively inhibits Bruton's tyrosine kinase (BTK), a critical enzyme in B-cell receptor signaling.
- By blocking BTK, Ibitra 200 Capsule disrupts the survival signals of malignant B-cells.
- This leads to apoptosis (programmed cell death) of cancerous cells.
- The drug also inhibits the proliferation of B-cells, reducing tumor burden.
- Ibrutinib has a long half-life, allowing for once-daily dosing.
How to use Ibitra 200 Capsule
- Take Ibitra 200 Capsule orally, with or without food.
- The typical dosage is one capsule daily, as prescribed by your healthcare provider.
- Swallow the capsule whole; do not crush or chew it.
- Maintain a consistent schedule for taking the medication each day.
- If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose.
- Do not double up on doses to make up for a missed one.
- Continue taking Ibitra 200 Capsule for the duration prescribed by your doctor, even if you feel well.
Lifestyle Advice
- Maintain a balanced diet rich in fruits, vegetables, and whole grains to support overall health.
- Stay hydrated by drinking plenty of water throughout the day.
- Avoid alcohol consumption as it may interact with the medication.
- Engage in regular physical activity as tolerated to enhance well-being and energy levels.
- Monitor your health closely and report any unusual symptoms to your healthcare provider promptly.
- Consider joining a support group for individuals undergoing similar treatments for emotional support.
Safety Advice
Side Effects
- Common side effects include diarrhea, fatigue, nausea, and headache.
- Some patients may experience rash or bruising easily.
- Serious side effects can include bleeding problems, heart rhythm changes, and liver function abnormalities.
- If you notice signs of infection such as fever or chills, seek medical attention immediately.
- Report any severe allergic reactions like rash, itching, or difficulty breathing to your doctor right away.
Precautions and Warnings
- Avoid use in patients with severe hepatic impairment.
- Monitor blood counts regularly during treatment due to potential cytopenias.
- Use caution in patients with a history of bleeding disorders.
- Pregnant or breastfeeding women should not use Ibitra 200 Capsule without consulting their healthcare provider.
- Avoid alcohol while taking this medication due to potential interactions.
- Inform your doctor about all medications you are taking to prevent drug interactions.
FAQs
1. What should I do if I miss a dose of Ibitra 200 Capsule?
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
2. Are there any food interactions with Ibitra 200 Capsule?
Ibitra 200 Capsule can be taken with or without food; however, avoid alcohol as it may affect how the medication works.
3. Who should avoid using Ibitra 200 Capsule?
Patients with known hypersensitivity to Ibrutinib or any component of the capsule should avoid using it.
4. What are the storage requirements for Ibitra 200 Capsule?
Store Ibitra 200 Capsule at room temperature, away from moisture and heat, and keep it out of reach of children.
5. Can I drive while taking Ibitra 200 Capsule?
Ibitra 200 Capsule may cause dizziness; therefore, exercise caution when driving or operating machinery.
6. What should I do if I experience side effects?
Contact your healthcare provider immediately if you experience severe side effects or any unusual symptoms.
7. Is it safe to take Ibitra 200 Capsule during pregnancy?
Ibitra 200 Capsule is not recommended during pregnancy; consult your doctor for alternatives.
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
2. Are there any food interactions with Ibitra 200 Capsule?
Ibitra 200 Capsule can be taken with or without food; however, avoid alcohol as it may affect how the medication works.
3. Who should avoid using Ibitra 200 Capsule?
Patients with known hypersensitivity to Ibrutinib or any component of the capsule should avoid using it.
4. What are the storage requirements for Ibitra 200 Capsule?
Store Ibitra 200 Capsule at room temperature, away from moisture and heat, and keep it out of reach of children.
5. Can I drive while taking Ibitra 200 Capsule?
Ibitra 200 Capsule may cause dizziness; therefore, exercise caution when driving or operating machinery.
6. What should I do if I experience side effects?
Contact your healthcare provider immediately if you experience severe side effects or any unusual symptoms.
7. Is it safe to take Ibitra 200 Capsule during pregnancy?
Ibitra 200 Capsule is not recommended during pregnancy; consult your doctor for alternatives.
Instructions
No content available for this section.
More Information
| SKU | E2276 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Linux Laboratories |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Ibitra 200 Capsule is a pharmaceutical product that contains the active ingredient Ibrutinib, which is classified as a Bruton's tyrosine kinase (BTK) inhibitor. This medication is primarily used in the treatment of various hematological malignancies, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Ibrutinib works by interfering with the signals that promote the growth and survival of cancer cells, thereby helping to control the disease. The formulation of Ibitra 200 Capsule ensures optimal bioavailability and efficacy, making it a vital component in the therapeutic regimen for patients diagnosed with these conditions. The capsule form allows for easy administration and absorption, contributing to patient compliance and overall treatment success. As a targeted therapy, Ibitra 200 Capsule represents a significant advancement in oncology, providing patients with a more effective option compared to traditional chemotherapy. It is essential for patients to consult their healthcare provider to determine if Ibitra 200 Capsule is appropriate for their specific medical condition and to discuss any potential risks or benefits associated with its use.
Uses & Benefits
- Effective in treating chronic lymphocytic leukemia (CLL).
- Used for managing mantle cell lymphoma (MCL).
- Helps in controlling disease progression in patients with specific hematological cancers.
- Targeted therapy that minimizes damage to healthy cells.
- Improves overall survival rates in certain cancer patients.
- Can be used in patients who have received prior therapies.
- May reduce the need for more aggressive treatments like chemotherapy.
How Ibitra 200 Capsule works
- Ibrutinib selectively inhibits Bruton's tyrosine kinase (BTK), a critical enzyme in B-cell receptor signaling.
- By blocking BTK, Ibitra 200 Capsule disrupts the survival signals of malignant B-cells.
- This leads to apoptosis (programmed cell death) of cancerous cells.
- The drug also inhibits the proliferation of B-cells, reducing tumor burden.
- Ibrutinib has a long half-life, allowing for once-daily dosing.
How to use Ibitra 200 Capsule
- Take Ibitra 200 Capsule orally, with or without food.
- The typical dosage is one capsule daily, as prescribed by your healthcare provider.
- Swallow the capsule whole; do not crush or chew it.
- Maintain a consistent schedule for taking the medication each day.
- If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose.
- Do not double up on doses to make up for a missed one.
- Continue taking Ibitra 200 Capsule for the duration prescribed by your doctor, even if you feel well.
Lifestyle Advice
- Maintain a balanced diet rich in fruits, vegetables, and whole grains to support overall health.
- Stay hydrated by drinking plenty of water throughout the day.
- Avoid alcohol consumption as it may interact with the medication.
- Engage in regular physical activity as tolerated to enhance well-being and energy levels.
- Monitor your health closely and report any unusual symptoms to your healthcare provider promptly.
- Consider joining a support group for individuals undergoing similar treatments for emotional support.
Side Effects
- Common side effects include diarrhea, fatigue, nausea, and headache.
- Some patients may experience rash or bruising easily.
- Serious side effects can include bleeding problems, heart rhythm changes, and liver function abnormalities.
- If you notice signs of infection such as fever or chills, seek medical attention immediately.
- Report any severe allergic reactions like rash, itching, or difficulty breathing to your doctor right away.
Precautions and Warnings
- Avoid use in patients with severe hepatic impairment.
- Monitor blood counts regularly during treatment due to potential cytopenias.
- Use caution in patients with a history of bleeding disorders.
- Pregnant or breastfeeding women should not use Ibitra 200 Capsule without consulting their healthcare provider.
- Avoid alcohol while taking this medication due to potential interactions.
- Inform your doctor about all medications you are taking to prevent drug interactions.
1. What should I do if I miss a dose of Ibitra 200 Capsule?
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
2. Are there any food interactions with Ibitra 200 Capsule?
Ibitra 200 Capsule can be taken with or without food; however, avoid alcohol as it may affect how the medication works.
3. Who should avoid using Ibitra 200 Capsule?
Patients with known hypersensitivity to Ibrutinib or any component of the capsule should avoid using it.
4. What are the storage requirements for Ibitra 200 Capsule?
Store Ibitra 200 Capsule at room temperature, away from moisture and heat, and keep it out of reach of children.
5. Can I drive while taking Ibitra 200 Capsule?
Ibitra 200 Capsule may cause dizziness; therefore, exercise caution when driving or operating machinery.
6. What should I do if I experience side effects?
Contact your healthcare provider immediately if you experience severe side effects or any unusual symptoms.
7. Is it safe to take Ibitra 200 Capsule during pregnancy?
Ibitra 200 Capsule is not recommended during pregnancy; consult your doctor for alternatives.
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose. Do not take two doses at once.
2. Are there any food interactions with Ibitra 200 Capsule?
Ibitra 200 Capsule can be taken with or without food; however, avoid alcohol as it may affect how the medication works.
3. Who should avoid using Ibitra 200 Capsule?
Patients with known hypersensitivity to Ibrutinib or any component of the capsule should avoid using it.
4. What are the storage requirements for Ibitra 200 Capsule?
Store Ibitra 200 Capsule at room temperature, away from moisture and heat, and keep it out of reach of children.
5. Can I drive while taking Ibitra 200 Capsule?
Ibitra 200 Capsule may cause dizziness; therefore, exercise caution when driving or operating machinery.
6. What should I do if I experience side effects?
Contact your healthcare provider immediately if you experience severe side effects or any unusual symptoms.
7. Is it safe to take Ibitra 200 Capsule during pregnancy?
Ibitra 200 Capsule is not recommended during pregnancy; consult your doctor for alternatives.
No content available for this section.
| SKU | E2276 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Linux Laboratories |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account